Nov 07, 2018
Champions Oncology to Participate in the 9th Annual Craig-Hallum Alpha Select Conference
Aug 28, 2018
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 13, 2018
Aug 08, 2018
Champions Oncology Granted Full Accreditation by the AAALAC
Jul 26, 2018
Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018
Jul 12, 2018
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 26, 2018
Jun 18, 2018
Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PDX Studies
May 03, 2018
Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9th
May 01, 2018
Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology Research
Apr 04, 2018
Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex House
Mar 15, 2018
Champions Oncology Reports Quarterly Revenue of $5.1 Million
Mar 07, 2018
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 15, 2018
Feb 26, 2018
Champions Oncology to Participate at the 30th Annual ROTH Conference
Dec 07, 2017
Champions Oncology Reports Record Quarterly Revenue of $5.2 Million
Nov 28, 2017
Champions Oncology to Announce Second Quarter Financial Results on Thursday, December 7, 2017
Nov 07, 2017
Champions Oncology to Participate in the Craig-Hallum Alpha Select Investor Conference
Sep 26, 2017
Champions Oncology announces $2 million award from the National Cancer Institute (NCI) to develop and evaluate prostate cancer PDX models
Sep 18, 2017
Champions Oncology announces publication highlighting clinical correlation between patient-derived xenograft (PDX) model responses and patient responses to oncology therapies
Sep 14, 2017
Champions Oncology Reports Record Quarterly Revenue of $5 Million
Sep 07, 2017
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 14, 2017
Aug 21, 2017
Champions Oncology Announces Strategic Collaboration with AstraZeneca to Develop Unique Cohorts of Patient-Derived Xenograft (PDX) Models